Affinage

SMG8

Nonsense-mediated mRNA decay factor SMG8 · UniProt Q8ND04

Length
991 aa
Mass
109.7 kDa
Annotated
2026-06-10
14 papers in source corpus 12 papers cited in narrative 12 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

SMG8 is a regulatory subunit of the SMG1 kinase complex (SMG1C) that tunes nonsense-mediated mRNA decay (NMD) by controlling the timing and stringency of SMG1-dependent UPF1 phosphorylation (PMID:19417104, PMID:26130714). Together with SMG9 it forms a G-domain heterodimer architecturally related to dynamin-like GTPases, in which nucleotide binds the SMG9 G domain rather than SMG8 (PMID:28389433); SMG9 scaffolds this module onto the N-terminal HEAT-repeat region of SMG1 and thereby recruits SMG8 (PMID:21245168). SMG8 binding drives large-scale HEAT-repeat conformational changes that propagate to and downregulate the SMG1 kinase domain, and its C-terminal kinase inhibitory domain (KID) caps the catalytic pocket to stabilize an autoinhibitory state of the SMG1 insertion domain (PMID:21245168, PMID:31729466, PMID:34698635). Within the SMG1-8-9-UPF1 assembly, SMG8/SMG9 promote high-affinity UPF1 capture while decelerating the kinase and enhancing phosphosite stringency, with UPF2 destabilizing the complex to release substrate (PMID:26130714). SMG8 also recruits SMG1 to the mRNA surveillance complex and is required for remodeling of the SURF complex into the DECID complex during NMD (PMID:19417104). In human cells SMG8 is a nonessential modulator: full loss causes only modest NMD impairment and the KID is dispensable for NMD in intact cells, yet SMG8-deficient cells become hypersensitive to partial SMG1 inhibition, defining a role in safeguarding NMD efficiency and perturbation tolerance (PMID:41830328). Loss-of-function in patients elevates NMD-substrate transcripts and UPF1 phosphorylation, consistent with relief of SMG1 inhibition in vivo (PMID:33242396), and loss of SMG8/SMG9 confers resistance to ATR inhibitors through an SMG1-mediated effect on replication stress responses (PMID:36273494).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 2009 High

    Established SMG8 as a bona fide subunit of the SMG1 complex with dual regulatory roles, answering whether NMD kinase activity is gated by dedicated accessory factors.

    Evidence Co-IP, RNAi knockdown, and mRNP/ribosome fractionation in mammals and C. elegans

    PMID:19417104

    Open questions at the time
    • Structural basis of kinase suppression unresolved
    • Molecular mechanism of SURF-to-DECID remodeling not defined
  2. 2011 High

    Resolved how SMG8 represses SMG1 without contacting the active site, showing allosteric control via the HEAT repeats and SMG9-dependent recruitment.

    Evidence EM 3D reconstruction with in vitro kinase and deletion/mutant assays

    PMID:21245168

    Open questions at the time
    • Atomic-resolution view of the inhibited kinase lacking
    • How conformational signal reaches catalytic pocket not pinpointed
  3. 2015 High

    Showed SMG8/SMG9 couple substrate recruitment to kinase regulation, capturing UPF1 with high affinity while slowing phosphorylation and sharpening site selection.

    Evidence Cryo-EM of SMG1-8-9-UPF1 in multiple states with in vitro kinase assays and reconstitution

    PMID:26130714

    Open questions at the time
    • Trigger that converts the complex from inhibited to active not defined
    • UPF2-mediated release kinetics in vivo unknown
  4. 2017 High

    Defined the SMG8-SMG9 core as a nucleotide-asymmetric G-domain heterodimer resembling dynamin-like GTPases, framing how a GTPase module could gate the kinase.

    Evidence 2.5 Å X-ray crystallography of C. elegans core with EM map fitting and conservation analysis

    PMID:28389433

    Open questions at the time
    • Functional consequence of SMG9 nucleotide binding in NMD not tested
    • Whether GTP turnover drives kinase activation unresolved
  5. 2019 High

    Defined the molecular basis of SMG1 autoinhibition within the SMG1-8-9 complex: an SMG8 KID occludes the catalytic pocket and an InsP6 cofactor is required for optimal substrate phosphorylation.

    Evidence Cryo-EM at 3.4–3.45 Å, MS identification of InsP6, and in vitro kinase assays with binding-site mutants

    PMID:31729466 PMID:31792449

    Open questions at the time
    • Direct demonstration that SMG9 GTP hydrolysis displaces the KID lacking
    • InsP6 dependence in cellular NMD not established
  6. 2021 High

    Clarified that SMG8 acts by stabilizing an intrinsic SMG1 autoinhibitory state in which the insertion domain blocks substrate access, refining the inhibition model.

    Evidence Cryo-EM (2.8–3.6 Å) of SMG1-9 and SMG1-8-9 with inhibitor and non-hydrolyzable ATP analog plus biochemical analysis

    PMID:34698635

    Open questions at the time
    • Physiological cue that relieves autoinhibition not identified
    • Dynamics of insertion-domain release not captured
  7. 2012 Medium

    Revealed species divergence by showing C. elegans smg-8 is dispensable for NMD, signaling that SMG8's contribution is not uniform across organisms.

    Evidence Four independent genetic NMD assays and phenotypic analysis of smg-8 mutants in C. elegans

    PMID:23166684

    Open questions at the time
    • Negative result; does not exclude conditional requirement
    • Contrasts mammalian data without reconciling mechanism
  8. 2013 Medium

    Demonstrated therapeutic relevance by showing SMG8 knockdown restores PTC-bearing transcripts and proteins with minimal cytotoxicity, nominating it as a low-toxicity NMD-inhibition target.

    Evidence siRNA screen of NMD factors in patient fibroblasts with mRNA/protein rescue and cell growth/cycle assays

    PMID:23983263

    Open questions at the time
    • Magnitude of NMD inhibition versus other factors not quantified mechanistically
    • Single lab, limited disease contexts
  9. 2020 Medium

    Confirmed in human patients that SMG8 loss relieves SMG1 inhibition in vivo, linking genetic deficiency to elevated UPF1 phosphorylation and NMD-substrate accumulation.

    Evidence RNA-seq and phospho-UPF1 immunoblotting in patient cells with loss-of-function variants

    PMID:33242396

    Open questions at the time
    • Disease mechanism downstream of dysregulated NMD not defined
    • Single study
  10. 2022 Medium

    Connected the SMG8/SMG9/SMG1 axis to replication stress, showing its loss confers ATR-inhibitor resistance by dampening transcription/replication conflicts.

    Evidence Genome-wide CRISPR-Cas9 resistance screen with DNA-damage marker imaging/immunoblotting and TRC measurement

    PMID:36273494

    Open questions at the time
    • Direct molecular link between NMD kinase control and TRCs unresolved
    • SMG1 substrates mediating the response not identified
  11. 2026 High

    Reframed SMG8 as a nonessential safeguard rather than a core NMD factor, showing the KID is dispensable in cells and full loss is only modestly impairing yet sensitizes cells to SMG1 inhibition.

    Evidence CRISPR deletion of SMG8 KID and full SMG8 across multiple human cell lines with RNA-seq, phospho-UPF1 immunoblotting, and pharmacological SMG1 inhibition

    PMID:41830328

    Open questions at the time
    • Reconciliation of in-cell KID dispensability with in vitro structural inhibition not fully explained
    • Conditions under which SMG8 becomes critical not enumerated

Open questions

Synthesis pass · forward-looking unresolved questions
  • The physiological trigger that converts the SMG8-stabilized autoinhibited SMG1 complex into an active kinase, and whether SMG9 GTP hydrolysis drives KID displacement in vivo, remain unresolved.
  • No in vivo demonstration of GTP-hydrolysis-coupled activation
  • Cellular signal/cofactor that times kinase activation unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 5 GO:0140096 catalytic activity, acting on a protein 3
Pathway
R-HSA-8953854 Metabolism of RNA 4
Partners
SMG1SMG9UPF1
Complex memberships
SMG1 kinase complex (SMG1C / SMG1-SMG8-SMG9)

Evidence

Reading pass · 12 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2009 SMG-8 and SMG-9 were identified as novel subunits of the SMG-1 complex. SMG-8 suppresses SMG-1 kinase activity in the isolated SMG-1 complex and recruits SMG-1 to the mRNA surveillance complex. Inactivation of SMG-8 induces accumulation of a ribosome:Upf1:eRF1:eRF3:EJC complex on mRNP, revealing that SMG-8 is required for proper remodeling of the SURF complex to the DECID complex during NMD. Co-immunoprecipitation, RNA interference knockdown, ribosome fractionation, mRNP complex analysis in mammals and C. elegans Genes & development High 19417104
2011 Cryo-EM structural analysis revealed that SMG-8 binds to the N-terminal HEAT repeat region of SMG-1 (scaffolded by SMG-9), and that SMG-8 binding induces large-scale conformational changes in the HEAT repeats that are transmitted to the kinase domain, down-regulating SMG-1 kinase activity on Upf1 without directly contacting the catalytic domain. SMG-9 controls SMG-1 activity indirectly by recruiting SMG-8 to the HEAT repeat region. Electron microscopy 3D reconstruction, in vitro kinase assays, deletion/mutant analysis Genes & development High 21245168
2015 Cryo-EM of the SMG-1-8-9-UPF1 complex showed that SMG-8 and SMG-9 interact with the SMG-1 C-terminal insertion domain and promote high-affinity UPF1 binding to SMG-1-8-9, while simultaneously decelerating SMG-1 kinase activity and enhancing stringency of phosphorylation site selection. UPF2 destabilizes the SMG-1-8-9-UPF1 complex, leading to substrate release. Electron cryo-microscopy, in vitro kinase assays, complex reconstitution Nucleic acids research High 26130714
2017 Crystal structure of the SMG8-SMG9 core complex from C. elegans at 2.5 Å revealed that SMG8-SMG9 forms a G-domain heterodimer with architectural similarities to dynamin-like GTPases (e.g., Atlastin, GBP1). The heterodimer forms in the absence of nucleotides; nucleotide binding occurs at the G domain of SMG9 but not SMG8. Interactions forming the heterodimer are conserved from worms to humans. X-ray crystallography (2.5 Å), fitting into EM density maps of human SMG1-SMG8-SMG9 RNA (New York, N.Y.) High 28389433
2019 3.45-Å cryo-EM structure of human SMG1-SMG8-SMG9 revealed the presence of inositol hexaphosphate (InsP6) bound in the SMG1 kinase domain. The InsP6-binding site is required for optimal in vitro phosphorylation of SMG1 substrates. This InsP6-binding site is conserved in mTOR and potentially other PIKK family members. Cryo-EM at 3.45 Å, mass spectrometry for InsP6 identification, in vitro kinase assay with InsP6-binding site mutants Nature structural & molecular biology High 31792449
2019 Cryo-EM structure of the SMG1-SMG8-SMG9 complex at 3.4 Å showed that SMG8 possesses a C-terminal kinase inhibitory domain (KID) that covers the catalytic pocket of SMG1, thereby inhibiting its kinase activity. Structural analyses suggested that GTP hydrolysis by SMG9 would induce a conformational change in SMG8-SMG9 causing the KID to move away from the inhibitory position, restoring SMG1 kinase activity. Cryo-EM at 3.4 Å, biochemical kinase inhibition assays Cell research High 31729466
2021 Cryo-EM reconstructions of SMG1-9 and SMG1-8-9 complexes bound to an inhibitor or non-hydrolyzable ATP analog (2.8–3.6 Å) showed that the SMG1 insertion domain exerts an autoinhibitory function by directly blocking the substrate-binding path and access to the active site, and that this autoinhibitory state is stabilized by the presence of SMG8. Cryo-EM (2.8–3.6 Å resolution), biochemical analysis with kinase inhibitor and ATP analog eLife High 34698635
2013 Knockdown of SMG-8 in patient-derived fibroblasts (Ullrich congenital muscular dystrophy and CARASIL) restored defective mRNA and protein levels from PTC-containing transcripts without affecting cell growth, cell-cycle progression, or ER stress, demonstrating that SMG-8 is a viable target for NMD inhibition with minimal cytotoxicity compared to other NMD factors. siRNA knockdown screening of 15 NMD factors, RT-PCR and Western blot for NMD substrate rescue, cell growth and cell-cycle assays Proceedings of the National Academy of Sciences of the United States of America Medium 23983263
2020 Loss-of-function variants in SMG8 in human patients resulted in a general increase in NMD substrate mRNA levels (RNA-seq) and increased phosphorylation of UPF1 (a key SMG1-dependent step), consistent with loss of SMG8-mediated inhibition of SMG1 kinase activity in vivo. RNA-seq of patient cells, phospho-UPF1 immunoblotting American journal of human genetics Medium 33242396
2022 CRISPR-Cas9 genome-wide screen identified that loss of SMG8 (or SMG9) causes resistance to ATR inhibitors via an SMG1-mediated mechanism. SMG8/9-defective cells showed reduced ATRi-induced transcription/replication conflicts (TRCs) and lacked characteristic ATRi responses (changes in ATM/CHK2, γH2AX, phospho-RPA, 53BP1), indicating that the SMG8/9/SMG1 pathway modulates cellular responses to replication stress. Genome-wide CRISPR-Cas9 positive selection screen, ATR inhibitor treatment, immunofluorescence and immunoblotting for DNA damage markers, TRC measurement Cancer research Medium 36273494
2012 In C. elegans, smg-8 mutations do not affect degradation of endogenous NMD targets (rpl-7a, rpl-12, unc-54(r293)) or exogenous NMD reporters, and smg-8 animals lack classical Smg mutant phenotypes, indicating that C. elegans SMG-8 is not a critical NMD component (negative finding, potentially species-specific). Genetic analysis using four independent NMD assays (endogenous NMD targets, exogenous reporter), phenotypic analysis of smg-8 mutants PloS one Medium 23166684
2026 Deletion of the SMG8 kinase inhibitory domain (KID) in human cells did not affect UPF1 phosphorylation or NMD efficiency in vivo, demonstrating the KID is dispensable for NMD in intact cells. Complete loss of SMG8 caused only modest NMD impairment with moderately increased UPF1 phosphorylation. However, SMG8-deficient cells showed pronounced hypersensitivity to partial pharmacological SMG1 inhibition, establishing SMG8 as a nonessential modulator that safeguards NMD efficiency and perturbation tolerance. CRISPR-Cas9 deletion of SMG8 KID and full SMG8 in multiple human cell lines, RNA-seq for NMD substrate levels, phospho-UPF1 immunoblotting, pharmacological SMG1 inhibitor treatment Nucleic acids research High 41830328

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2009 SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay. Genes & development 199 19417104
2011 The nonsense-mediated mRNA decay SMG-1 kinase is regulated by large-scale conformational changes controlled by SMG-8. Genes & development 71 21245168
2015 A network of SMG-8, SMG-9 and SMG-1 C-terminal insertion domain regulates UPF1 substrate recruitment and phosphorylation. Nucleic acids research 52 26130714
2019 InsP6 binding to PIKK kinases revealed by the cryo-EM structure of an SMG1-SMG8-SMG9 complex. Nature structural & molecular biology 31 31792449
2013 Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America 28 23983263
2019 Cryo-EM structure of SMG1-SMG8-SMG9 complex. Cell research 27 31729466
2021 Cryo-EM reconstructions of inhibitor-bound SMG1 kinase reveal an autoinhibitory state dependent on SMG8. eLife 26 34698635
2020 Recessive, Deleterious Variants in SMG8 Expand the Role of Nonsense-Mediated Decay in Developmental Disorders in Humans. American journal of human genetics 25 33242396
2022 SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance. Cancer research 14 36273494
2017 Structure of a SMG8-SMG9 complex identifies a G-domain heterodimer in the NMD effector proteins. RNA (New York, N.Y.) 11 28389433
2012 Genetic characterization of smg-8 mutants reveals no role in C. elegans nonsense mediated decay. PloS one 11 23166684
2021 Expanding the phenotypic and allelic spectrum of SMG8: Clinical observations reveal overlap with SMG9-associated disease trait. American journal of medical genetics. Part A 5 34761517
2023 Expanding the genetic spectrum of ALKU syndrome: Compound heterozygosity for two deleterious variants in SMG8 gene. American journal of medical genetics. Part A 1 37194129
2026 SMG1:SMG8:SMG9-complex integrity supports efficient execution of nonsense-mediated mRNA decay. Nucleic acids research 0 41830328

Missed literature

Know a paper Affinage missed for SMG8? Flag it for the maintainers and the community.

No submissions yet.